Department of Clinical Application, Cebter for ips cell Research and Application, 53 Kawahara-cho Shogoin Sakyo-ku, Kyoto,

Similar documents
Recent Progress in ips Cell Research and Application

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

Wider Adoption of Regenerative Medicine Driven by Open Innovation

PRIME-XV Cell Therapy Products by

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Des cellules-souches dans le poumon : pourquoi faire?

Stem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center

ADVANCED MEDIA TECHNOLOGY

Insight to Gene Techno Science Co.,Ltd

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

Immunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications

ips Cell Induction from Human Non-T, B Cells from Peripheral Blood Keisuke Okita *

Transfection of Mouse ES Cells and Mouse ips cells using the Stemfect 2.0 -mesc Transfection Reagent

CENTER FOR BRAIN EXPERIMENT

Research Center Network for Realization of Regenerative Medicine

Stem Cells. for Journalists, Policymakers, and Campaigns

CURRENT ISSUE SUBSCRIBE AD LINK 1/10/2010 3:14 PM. SUBSCRIBE Blog with us: BLOGbiotech. (view larger image)

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT

Should Embryonic Stem Cell Research be Permitted to Continue? Over the past few years a debate has been going on over the moral implications of

leading the way in research & development

The science behind Betalutin : why is it unique? Roy H. Larsen PhD Sciencons AS, Oslo, Norway

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form

INNOVATIVE PRODUCTS FOR NEUROSCIENCE RESEARCH

Contents. The Right Surface for Every Cell Extracellular Matrices and Biologically Coated Surfaces ECM Mimetic and Advanced Surfaces...

White Paper Authentic Recombinant Activin A and BMP- 4 Production Using HumanZyme s Proprietary Human Cell Line Expression Technology

Stem Cells: A Primer National Institutes of Health

Relative cost of hepatocytes

Effect of Magnetic Field on Adhesion of Muscle Cells to Culture Plate

Regulatory Pathways for Rare Diseases

Stem Cells for the Future Treatment of Parkinson's Disease

InVivo Therapeutics. Developing Innovative Products for Spinal Cord Injury

Developmental Biology. Cell Fate, Potency, and Determination

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

The optimal source of stem cells for regenerative medicine is a ARTICLE. Biochemistry

Regulatory Updates on Cellular Therapy Products in Japan

Stem Cell Principle -

Yukio Kato, ph. D. July 11, 2014

Cytomics in Action: Cytokine Network Cytometry

Voyager Therapeutics - A Spinout from UMass Gene Therapy and RNAi Technologies

Isolation and Analysis of Pluripotent, Neural, and Hematopoietic Stem Cells

Patient Handbook on Stem Cell Therapies

Honors 177 MIDTERM. OncoProbe

Improving stem cell purity using microfluidics

Electron microscopy technology of reticulocytes after sorting with

Journal of Neuroscience Research 89: (2011) The balance of bone morphogenic protein (BMP), transforming

At the conclusion of this lesson you should be able to:

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management

Blue Marble University Biology Course Handbook

hpsc Maintenance Media

Versatility and performance of Lipofectamine Stem Transfection Reagent

Fujifilm s Initiatives in Regenerative Medicine

Prof. Giacomo P. Comi Dino Ferrari Center Department of Neurological Sciences University of Milan, Italy

Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. JournalClub Emilie Hrdliczka

FDA Regulation of Stem-Cell Based Therapies Dina Gould Halme, Ph.D., and David A. Kessler, M.D.

Nucleofector Technology in. Somatic Stem Cell Research. gene transfer begins here

Updates on global movement in regulation of Advanced Therapeutics

ReproRNA -OKSGM is a non-integrating, self-replicating RNA-based reprogramming vector for generating induced pluripotent stem (ips)

Stem cells have the ability to build every tissue in

Stem Cells and Tissue Regeneration

Pluripotent stem cells in regenerative medicine: challenges and recent progress

V4: cellular reprogramming

Curriculum Vitae of PATRIZIA PESSINA

Case Study: Examples Relating to the Quality Control of Cell-based Products

FACT - CIBMTR Data Audit Collaboration

POFILE: EDUCATION & TRAINING: WORKING EXPERIENCE:

NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE.

The promise of T cell engineering CD19 CAR therapy A prologue to immune regenerative medicine Vast potential, patience, public education

Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications -

HL 7 FHIR and the Future of Interoperability. January 25, pm 3pm ET

A simple choice. Essential 8 Media

DARATUMUMAB, A CD38 MONOCLONAL ANTIBODY IN PATIENTS WITH MULTIPLE MYELOMA Data from the dose-escalation part of the FIH study Abstract #8512

Ethical Challenges in Stem Cell Research and Treatment

Stem Cells and Cell Culture Developments Within ThermoFisher Scientific

FAX: WEB:

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

4 th Cell Therapy Conference: Manufacturing and Testing of Pluripotent Stem Cells

Primiano Pio Di Mauro, Biomedical Engineer, PhD in Bioengineering

CD133 (Prominin-1) Monoclonal Antibody (13A4), APC, ebioscience Catalog Number Product data sheet

Judy I. Eidelson, Ph.D.

Vir B. Singh, PhD

Eric W. Abelquist, Ph.D., CHP President, Health Physics Society. August 2017

GENESDEV/2007/ Supplementary Figure 1 Elkabetz et al.,

FP7 REGPOT Project coordinator: Srećko Gajović

FREQUENTLY ASKED QUESTIONSON STEM CELLS AND THEIR CLINICAL APPLICATIONS/THERAPY

Special Report. medicine? Peter Marks, M.D., Ph.D., and Scott Gottlieb, M.D.

ips cell technologies: significance and applications to CNS regeneration and disease

The School of Science and Engineering

-Immune phenotype -Cancer xenografts -Immune system humanization -Services

Production Assistance for Cellular Therapies PACT

Transcription:

Department of Clinical Application, Cebter for ips cell Research and Application, Kyoto University 53 Kawahara-cho Shogoin Sakyo-ku, Kyoto, 606-8507 JAPAN Phone: 81-75-366-7066, Fax: 81-75-366-7071 Daisuke Doi, MD, PhD Email: daisuke.doi@cira.kyoto-u.ac.jp Date of Birth: Mar 08, 1977 Nationality: Japan Education Years Degree Institute and Location 1995-2001 M.D. Shiga University of Medical Science, Shiga, Japan 2006-2010 Ph.D. Kyoto University Graduate School of Medicine, Kyoto, Japan Positions 2001 Resident, Department of Neurosurgery, Kyoto University Hospital, Kyoto, Japan 2002-2003 Clinical staff, Department of Neurosurgery, Yamatotakada Municipal Hospital, Nara, Japan 2004-2005 Clinical staff, Department of Neurosurgery, Kurashiki Central Hospital, Okayama, Japan 2005-2006 Clinical staff, Department of Neurosurgery, Kyoto University Hospital, Kyoto, Japan 2010-2016 Postdoctoral researcher, Department of Cell Growth and Differentiation, Center for ips Cell Research and Application, Kyoto University, Kyoto, Japan

2016-present Assistant Professor, Department of Clinical Application, Center for ips Cell Research and Application, Kyoto University, Kyoto, Japan Research Skills Cell culture: ES cells (mouse and human) and ips cells. In vivo skills: generating model animals of Parkinson s disease (rat), cell transplantation, and behavioral assessment. Staining: Immunohistochemistry in vitro and in vivo, analysis with a confocal microscope. Cell sorter: Analysis and cell sorting with fluorescence-activated cell sorter (FACS) and magnetic cell sorter (MACS). License and Certifications 2001 Japan Medical License 2010 Japanese Board of Neurosurgery 2012 PhD, Kyoto University Graduate School of Medicine 2015 Certifying physician of Japanese society for Regenerative Medicine Selected Publications Katsukawa M, Nakajima Y, Fukumoto A, Doi D, Takahashi J. Fail-safe Therapy by Gamma-Ray Irradiation Against Tumor Formation by Human Induced Pluripotent Stem Cell-Derived Neural Progenitors. Stem Cells Dev 25, 815-825 (2016). Nishimura K, Doi D, Samata B, Murayama S, Tahara T, Onoe H, Takahashi J. Estradiol Facilitates Functional Integration of ipsc-derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1.

Stem Cell Reports 6, 511-524 (2016) Doi D, Samata B, Katsukawa M, Kikuchi T, Morizane A, Ono Y, Sekiguchi K, Nakagawa M, Parmar M, Takahashi J. Isolation of Human Induced Pluripotent Stem Cell-derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation. Stem Cell Reports 2, 337-350 (2014) Nakagawa M, Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K, Morizane A, Doi D, Takahashi J, Nishizawa M, Yoshida Y, Toyoda T, Osafune K, Sekiguchi K and Yamanaka S. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 4, 3594 (2014). Morizane A, Doi D, Kikuchi T, Okita K, Hotta A, Kawasaki T, Hayashi T, Onoe H, Shiina T, Yamanaka S and Takahashi J. Direct Comparison of Autologous and Allogeneic Transplantation of ipsc-derived Neural Cells in the Brain of a Nonhuman Primate. Stem Cell Reports 1, 283-292 (2013). Morizane A, Doi D & Takahashi J. Neural induction with a dopaminergic phenotype from human pluripotent stem cells through a feeder-free floating aggregation culture. Methods Mol Biol 1018, 11-19 (2013). Shinoyama M, Ideguchi M, Hayashi H, Doi D, Hashimoto N, Suzuki M and Takahashi J. Cytotoxic T lymphocyte antigen 4 immunogloblin promotes neuronal differentiation in the grafts of embryonic stem cell-derived neural precursor cells. Neuroscience 202, 484-491 (2012). Doi D, Morizane A, Kikuchi T, Onoe H, Hayashi T, Kawasaki T, Motono M, Sasai Y, Saiki H, Gomi M, Yoshikawa T, Hayashi H, Shinoyama M, Refaat M.M, Suemori H, Miyamoto S and Takahashi J. Prolonged Maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease.

Stem Cells 30(5): 935-945 (2012). Gomi M, Takagi Y, Morizane A, Doi D, Nishimura M, Miyamoto S, Takahashi J. Functional recovery of the murine brain ischemia model using human induced pluripotent stem cell-derived telencephalic progenitors. Brain Res. 1459: 52-60 (2012) Kikuchi T, Morizane A, Doi D, Onoe H, Hayashi H, Kawasaki T, Saiki H, Miyamoto S, and Takahashi J. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. J. Parkinson's Disease 1(4):395-412 (2011) Morizane A, Doi D, Kikuchi T, Nishimura K and Takahashi J. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J. Neurosci. Res. 89(2):117-126 (2011) Koyanagi M, Takahashi J, Arakawa Y, Doi D, Fukuda J, Hayashi H, Narumiya S, and Hashimoto N Inhibition of the Rho/ROCK pathway reduced apoptosis during transplantation of embryonic stem cell-derived neural precursors. J. Neurosci. Res. 86(2):270-280 (2008) Selected Presentations Neuroscience 2008 (Society for neuroscience), Washington DC, 2008 Nov 18, Analysis of the human ES cell-derived tumor in the primate model of Parkinson s disease Neuroscience 2009 (Society for neuroscience), Chicago, Illinois, 2009 Oct 20, Characterization of human embryonic stem cell-derived tumors in the brain of monkey Parkinson s disease model (Poster presentation). Neuroscience 2010 (Society for neuroscience), San Diego, California, 2010 Nov 15, Sorting and transplantation of neural progenitor cells derived from human pluripotent stem cells ISSCR 9th Annual meeting (International Society for Stem Cell Research), Toronto, Canada, 2011 Jun 16, Sorting and transplantation of dopaminergic progenitor cells derived from human pluripotent stem cells

ISSCR 10th Annual meeting (International Society for Stem Cell Research), Yokohama, Japan, 2012 Jun 14, Sorting and transplantation of dopaminergic progenitor cells derived from human pluripotent stem cells ISSCR 11th Annual meeting (International Society for Stem Cell Research), Boston, USA, 2013 Jun 13, Sorting and transplantation of dopaminergic progenitor cells derived from human pluripotent stem cells The 7th Takeda Science Foundation Symposium on PharmaSciences/CiRA International Symposium 2014, Osaka, Japan, 2014 Jan 16, Sorting and transplantation of dopaminergic progenitor cells derived from human pluripotent stem cells ISSCR 13th Annual meeting (International Society for Stem Cell Research), Stockholm, Sweden, 2015 Jun 24, A clinical study of autologous transplantation using ipsc-derived dopaminergic progenotors to Parkinson s disease patients ISSCR 14th Annual meeting (International Society for Stem Cell Research), San Francisco, USA, 2016 Jun 24, Quality control of ipsc-derived dopaminergic cell grafts for Parkinson s disease patients (poster presentation).